Fingerprint
Dive into the research topics where Andreas Lauer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results
Yang, P., Birch, D., Lauer, A., Sisk, R., Anand, R., Pennesi, M. E., Iannaccone, A., Yaghy, A., Scaria, A., Jung, J. A., Curtiss, D. & Waheed, N. K., Mar 1 2025, In: American journal of ophthalmology. 271, p. 268-285 18 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Scopus citations -
XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa
XOLARIS Study Group, Jan 1 2025, In: Ophthalmology Science. 5, 1, 100595.Research output: Contribution to journal › Article › peer-review
Open Access9 Link opens in a new tab Scopus citations -
Partial rescue of the full-field electroretinogram in patients with RPE65-related retinal dystrophy following gene augmentation therapy with voretigene neparvovec-rzyl
Amato, A., Tschetter, W., Everett, L., Bailey, S. T., Lauer, A. K., Yang, P. & Pennesi, M., Oct 1 2024, In: Documenta Ophthalmologica. 149, 2, p. 63-75 13 p.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Scopus citations -
Preformed Vesicle Approach to LNP Manufacturing Enhances Retinal mRNA Delivery
Eygeris, Y., Henderson, M. I., Curtis, A. G., Jozić, A., Stoddard, J., Reynaga, R., Chirco, K. R., Su, G. L. N., Neuringer, M., Lauer, A. K., Ryals, R. C. & Sahay, G., Sep 12 2024, In: Small. 20, 37, 2400815.Research output: Contribution to journal › Article › peer-review
Open Access22 Link opens in a new tab Scopus citations -
Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study
Yang, P., Pardon, L. P., Ho, A. C., Lauer, A. K., Yoon, D., Boye, S. E., Boye, S. L., Roman, A. J., Wu, V., Garafalo, A. V., Sumaroka, A., Swider, M., Viarbitskaya, I., Aleman, T. S., Pennesi, M., Kay, C. N., Fujita, K. P. & Cideciyan, A. V., Sep 7 2024, In: The Lancet. 404, 10456, p. 962-970 9 p.Research output: Contribution to journal › Article › peer-review
29 Link opens in a new tab Scopus citations